Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q2 EPS of ($0.97), $0.92 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $807 million versus the consensus estimate of $693.39 million.

For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.